|
WO2021005623A1
|
|
A vaccine formulation for protection against enterotoxigenic e. coli (etec) and cholera
|
|
WO2020008475A1
|
|
Novel shigella vaccine formulation and process to prepare thereof
|
|
WO2019198096A1
|
|
Tetravalent meningococcal vaccine composition and process to prepare thereof
|
|
WO2019175900A1
|
|
Purification of neisseria meningitidis polysaccharides
|
|
WO2019145981A1
|
|
Novel meningococcal vaccine composition and process thereof
|
|
WO2019138432A1
|
|
Media composition for production of bacterial polysaccharides
|
|
CN110892077A
|
|
Purification of bacterial polysaccharides
|
|
CN110799650A
|
|
Production of bacterial polysaccharides
|
|
CN110809477A
|
|
Novel multivalent polysaccharide-protein conjugate vaccine compositions and formulations thereof
|
|
WO2018173068A1
|
|
A novel synthetic neisseria meningitidis serogroup a oligomer and process for synthesizing thereof
|
|
AU2017234319A1
|
|
Novel polysaccharide-protein conjugates and process to obtain thereof
|
|
CN106999563A
|
|
Method for the stable oral bacterial vaccine of preparating acid
|
|
US2017173145A1
|
|
Thermostable spray dried rotavirus vaccine formulation and process thereof
|
|
CN106794145A
|
|
Thermally-stabilised lyophilized rotavirus vaccine formulations and preparation method thereof
|
|
CA2939887A1
|
|
Novel oligomers and process of preparing thereof
|
